Regencell Bioscience Holdings Limited (NASDAQ: RGC)
$3.42
+0.0650 ( +1.94% ) 0.3K
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Market Data
Open
$3.42
Previous close
$3.35
Volume
0.3K
Market cap
$41.69M
Day range
$3.27 - $3.58
52 week range
$3.13 - $22.20
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 2 | Jun 20, 2024 |
| 6-k | Quarterly Reports | 2 | Jan 02, 2024 |
| 6-k | Quarterly Reports | 2 | Dec 15, 2023 |
| 20-f | Annual reports | 70 | Oct 27, 2023 |